LGLaurent Gétaz

Laurent Gétaz

*This is an algorithmically generated author record based on publicly available information.

Laurent Gétaz has a total of 241 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Declaración de Cochabamba 2023 a propósito de la estrongiloidiasis, contra el microgusano del barro: es hora de actuar

    by Laurent Gétaz

    El quinto congreso internacional de infectología se celebró del 15 al 17 de febrero de 2023 en Cochabamba, en el que se organizó un simposio sobre la estrongiloidiasis sobre el tema: “Es hora de actuar”. Es en esta ciudad de los valles interandinos, situada a 2.500 metros, con un clima templado, que se demostró por primera vez que este parasito tropical y subtropical se transmite también a una altitud tan elevada. La estrongiloidiasis, causada por el Strongyloides stercoralis, o más simplemente denominado “microgusano del barro”, es la helmintiasis intestinal más frecuente y grave en las regiones de Bolivia donde se investigó. La estrongiloidiasis, una de las enfermedades tropicales desatendidas más olvidadas, suele permanecer paucisintomática durante décadas en personas inmunocompetentes, pero provoca hiperinfestaciones parasitarias con altas tasas de mortalidad en individuos inmunodeprimidos. Las larvas se multiplican en el intestino, atraviesan la pared intestinal diseminándose a todos los órganos, y transportando en los vasos sanguíneos bacterias fecales, causando sepsis severa. Los corticosteroides, aun prescrito a corto plazo, son uno de los principales factores de riesgo de progresión a síndrome de hiperinfestación y estrongiloidiasis diseminada. Estos últimos años, se ha demostrado que la estrongiloidiasis es altamente endémica en Bolivia: 20% de las personas en alto riesgo de complicaciones son infectados en los departamentos de Cochabamba y Santa Cruz. Se demostró la presencia del microgusano del barro también en el Chaco y en el departamento de La Paz. En otras regiones faltan datos epidemiológicos. La enfermedad afecta a las personas que viven en las regiones endémicas. Pero también debido a las migraciones internas, las personas que viajan o trabajan en regiones endémicas pueden infectarse y quedar infectadas de por vida cuando regresan a regiones del Altiplano. La falta de sensibilidad de las pruebas coprológicas habituales ha contribuido a mantener esta enfermedad desatendida. Para diagnosticar este parásito, deben combinarse técnicas específicas de análisis de heces, como la técnica de Baermann, y la serología. Para la técnica Baermann, todo el equipo necesario está disponible y se fabrica en Bolivia. Para el reto del tratamiento, se ofrece una solución muy accesible: la ivermectina es el antiparasitario de primera elección. Es un medicamento barato, eficaz, disponible en Bolivia y con muy pocos efectos secundarios cuando se prescribe a la dosis adecuada. Participantes en la mesa redonda, implicados desde varios años en la mejora del conocimiento de esta enfermedad en Bolivia, y participantes al simposio, son signatarios de esta declaración, que propone un planteamiento en 4 etapas que ayudará a lograr el objetivo del control de la estrongiloidiasis.


  • Open Access

    Manejo de la estrongiloidiasis: revisión de la literatura con enfoque en la epidemiología en Bolivia

    by Laurent Gétaz, Maria del Rosario Castro Soto

    La estrongiloidiasis es una de las enfermedades parasitarias más desatendidas. Tiene una elevada morbilidad y mortalidad en personas tratadas con corticosteroides o con una inmunidad reducida por otros motivos. En Bolivia los estudios realizados han demostrado una alta prevalencia y su transmisión en diversas regiones tropicales y de los valles interandinos. Aunque la enfermedad no se transmite en climas fríos, todas las regiones de Bolivia pueden verse afectadas debido a la migración interna de la población. Las personas pueden infectarse al viajar a regiones endémicas décadas antes de presentar síntomas, porque si se deja sin tratar, puede persistir de por vida. La baja sensibilidad de las pruebas diagnósticas coproparasitológicas utilizadas de rutina dificultan su diagnóstico, pero existen técnicas de diagnóstico más eficientes a bajo costo como la técnica de Baermann modificada. La ivermectina es el tratamiento de elección, muy eficaz, bien tolerado cuando es prescrito a dosis adecuada, accesible y disponible en Bolivia.


  • Open Access

    Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study

    by Nicolas Tebib, Nathalie Tebib, Mauricio Paredes, Rosario Castro, Stéphanie Baggio, Mario Villarroel Torrico, Amilcar Alejandro Flores Leon, Maya Herbas Zamorano, Francois Chappuis, Laurent Getaz

    Background: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and organ transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia. Methods: A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 m, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test for S.stercoralis diagnosis. Results: In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%–25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the actual prevalence was 15.1% (95% CI: 9.4%–20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%–6.68%). No potential risk factors were significantly associated with S. stercoralis infection. Conclusions: We found a high seroprevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis.


  • Open Access

    Prevalence and Risk Factors of Strongyloides stercoralis in Haemodialysis in Cochabamba, Bolivia: A Cross-Sectional Study

    by Nicolas Tebib, Nathalie Tebib, Mauricio Paredes, Rosario Castro, Stéphanie Baggio, Mario Villarroel Torrico, Amilcar Alejandro Flores Leon, Maya Herbas Zamorano, Francois Chappuis, Laurent Getaz

    Background: Strongyloidiasis is an infectious disease that can be fatal in immunocompromised patients. Patients with end-stage renal failure who are on dialysis have a considerably weakened immune system, and kidney transplantation is a major risk factor for severe strongyloidiasis. Knowledge of the local epidemiology in tropical and subtropical areas is an essential prerequisite for designing an appropriate strategy to prevent this potentially lethal complication. In this study, we aimed to estimate the prevalence and associated risk factors of S. stercoralis infection in patients on dialysis in Cochabamba, Bolivia.Methods: A cross-sectional study was carried out among patients undergoing haemodialysis in Cochabamba (elevation 2,500 metres, temperate climate), collecting information on socio-demographic, lifestyle, and clinical variables, and using one coproparasitological technique (the modified Baermann technique) and one serological (ELISA) test.Results: In total, 149 patients participated in the study (mean age = 51.4 years, 48.3% male). End-stage renal disease was predominantly (59%) of hypertensive and/or diabetic origin. The positive serological prevalence was 18.8% (95% CI: 13.3%–25.9%). Based on the sensitivity and specificity of the ELISA test, the estimate of the true prevalence was 15.1% (95% CI: 9.4%–20.7%). Stool samples of 105 patients (70.5%) showed a coproparasitological prevalence of 1.9% (95% CI: 0.52%–6.68%). No potential risk factors were significantly associated with S. stercoralis infection.Conclusions: We found a high prevalence of S. stercoralis in Bolivian patients undergoing haemodialysis in Cochabamba. We recommend presumptive antiparasitic treatment at regular intervals to avoid the potentially fatal complications of severe strongyloidiasis.

  • Open Access

    A Practical Approach to Screening for Strongyloides stercoralis

    by Luisa Carnino, Jean-Marc Schwob, Laurent Gétaz, Beatrice Nickel, Andreas Neumayr, Gilles Eperon

    Strongyloides stercoralis, causative agent of a neglected tropical disease, is a soil-transmitted helminth which may cause lifelong persisting infection due to continuous autoinfection. In the case of immunosuppression, life-threatening hyperinfection and disseminated strongyloidiasis can develop. We propose a pragmatic screening algorithm for latent strongyloidiasis based on epidemiologic exposure and immunosuppression status that can be applied for any kind of immunosuppressive therapy. The algorithm allows the diagnosis of latent strongyloidiasis with optimal accuracy in a well-equipped setting, while for endemic settings where the complete testing array is unavailable, an empiric treatment is generally recommended. Accurate diagnosis and extensive empiric treatment will both contribute to decreasing the current neglect of strongyloidiasis.


  • Open Access

    SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort

    by Florian Laubscher, Samuel Cordey, Alex Friedlaender, Cecilia Schweblin, Sarah Noetzlin, Pierre-François Simand, Natacha Bordry, Filipe De Sousa, Fiona Pigny, Stephanie Baggio, et al.

    Background: Oncological patients have a higher risk of prolonged SARS-CoV-2 shedding, which, in turn, can lead to evolutionary mutations and emergence of novel viral variants. The aim of this study was to analyze biological samples of a cohort of oncological patients by deep sequencing to detect any significant viral mutations. Methods: High-throughput sequencing was performed on selected samples from a SARS-CoV-2-positive oncological patient cohort. Analysis of variants and minority variants was performed using a validated bioinformatics pipeline. Results: Among 54 oncological patients, we analyzed 12 samples of 6 patients, either serial nasopharyngeal swab samples or samples from the upper and lower respiratory tracts, by high-throughput sequencing. We identified amino acid changes D614G and P4715L as well as mutations at nucleotide positions 241 and 3037 in all samples. There were no other significant mutations, but we observed intra-host evolution in some minority variants, mainly in the ORF1ab gene. There was no significant mutation identified in the spike region and no minority variants common to several hosts. Conclusions: There was no major and rapid evolution of viral strains in this oncological patient cohort, but there was minority variant evolution, reflecting a dynamic pattern of quasi-species replication.


  • Open Access

    Case Report: Don’t chew the fufu: a case report of suspected drug body stuffing

    by Naya Jimenez, Nguyen Toan Tran, Pierre-Alexandre Poletti, Alexandra Platon, Francesco Meach, André Juillerat, Laurent Getaz, Hans Wolff

    Background: Intrabody concealment of illicit substances is a common practice in the trafficking chain. Body packing is a technique used in drug trafficking that consists of deliberately ingesting many drug pellets. Body stuffing consists of precipitously swallowing packets of substances, which are smaller and more fragile than body-packing pellets, for concealment from law-enforcement officers in anticipation of impending search or arrest. Therefore, body stuffing is particularly dangerous due to the rupture risk of the loosely wrapped drug packets, which could lead to substance intoxication or even death. Case presentation: This article reports the case of a young man who was taken by law enforcement authorities to our Emergency Department for investigation of suspected body stuffing. Although the patient denied the facts, the initial reading of the computed tomography (CT) scan confirmed the presence of multiple images compatible with drug pellets, which were mostly in the stomach. The pellet findings were more consistent with body packing than body stuffing as initially suspected by the police. However, upon admission to our secured inpatient ward for clinical surveillance of pellet evacuation, the patient denied again having ingested such pellets, and declared that he only ate ‘fufu’. Fufu is a traditional food of central and western Africa consisting of a starchy preparation compacted by hand into small balls. Fufu balls are usually swallowed without chewing to allow a sensation of stomach fullness throughout the day. Considering the fufu intake history, a careful reassessment of the imaging confirmed the presence of food content. Conclusions: This case study offers an example of suspected intrabody concealment of illicit substances, which turned out to be false positive due to fufu. It illustrates the importance of a history of food intake that could bias the interpretation of CT scan images.

  • Open Access

    Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample

    by Silvia Stringhini, Ania Wisniak, Giovanni Piumatti, Andrew S. Azman, Stephen A. Lauer, Hélène Baysson, David De Ridder, Dusan Petrovic, Stephanie Schrempft, Kailing Marcus, et al.

    Background: Assessing the burden of COVID-19 based on medically-attended case counts is suboptimal given its reliance on testing strategy, changing case definitions and the wide spectrum of disease presentation. Population-based serosurveys provide one avenue for estimating infection rates and monitoring the progression of the epidemic, overcoming many of these limitations. Methods: Taking advantage of a pool of adult participants from population-representative surveys conducted in Geneva, Switzerland, we implemented a study consisting of 8 weekly serosurveys among these participants and their household members older than 5 years. We tested each participant for anti-SARS-CoV-2-IgG antibodies using a commercially available enzyme-linked immunosorbent assay (Euroimmun AG, Lübeck, Germany). We estimated seroprevalence using a Bayesian regression model taking into account test performance and adjusting for the age and sex of Geneva’s population. Results: In the first three weeks, we enrolled 1335 participants coming from 633 households, with 16% <20 years of age and 53.6% female, a distribution similar to that of Geneva. In the first week, we estimated a seroprevalence of 3.1% (95% CI 0.2-5.99, n=343). This increased to 6.1% (95% CI 2.69.33, n=416) in the second, and to 9.7% (95% CI 6.1-13.11, n=576) in the third week. We found that 5-19 year-olds (6.0%, 95% CI 2.3-10.2%) had similar seroprevalence to 20-49 year olds (8.5%, 95%CI 4.99-11.7), while significantly lower seroprevalence was observed among those 50 and older (3.7%, 95% CI 0.99-6.0, p=0.0008). Interpretation: Assuming that the presence of IgG antibodies is at least in the short-term associated with immunity, these results highlight that the epidemic is far from burning out simply due to herd immunity. Further, no differences in seroprevalence between children and middle age adults are observed. These results must be considered as Switzerland and the world look towards easing restrictions aimed at curbing transmission.


  • Open Access

    Infectious diseases in post-trial detention and comparisons with pre-trial detention: A study in Geneva, Switzerland

    by Stéphanie Baggio, Komal Chacowry Pala, Jean-Pierre Rieder, Nguyen Toan Tran, Hans Wolff, Laurent Gétaz


  • Open Access

    Do Overcrowding and Turnover Cause Violence in Prison?

    by Stéphanie Baggio, Nicolas Peigné, Patrick Heller, Laurent Gétaz, Michael Liebrenz, Hans Wolff

    Violence is common in prison and its individual risk factors are well documented. However, there is a mixed evidence on the relationship between prison violence and institutional factors, such as overcrowding and turnover, and recent research suggested that these factors may not be important or relevant. This study investigated the association between prison violence and institutional factors in a Swiss pre-trial prison between 2013 and 2018. Measures included violence (assaults requiring immediate medical attention) as well as the annual overcrowding and turnover rates. Using a meta-regression, the results showed that prison violence was higher when overcrowding and turnover increased. Overall, our study highlighted that institutional prison factors might have notable detrimental effects on prison life. Reduction of prison overcrowding and turnover appear critical to reduce prisoners’ vulnerability. Turning prison into safe places designed to promote desistance would probably not be achievable without considering these crucial factors.